Capitolis Liquid Global Markets’s CVS Health CVS Stock Holding History

Capitolis Liquid Global Markets’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.1M	Sell	97,303 -57,695	-37%	-$5.15M	0.04%	198
2026 Q1	$11.1M	Sell	154,998 -18,777	-11%	-$1.45M	0.07%	171
2025 Q4	$13.8M	Buy	173,775 +23,775	+16%	+$1.87M	0.08%	133
2025 Q3	$11.3M	Buy	+150,000	New	+$10.3M	0.09%	129
2025 Q2	–	Sell	-381,000	Closed	-$25.8M	–	264
2025 Q1	$25.8M	Buy	+381,000	New	+$22.8M	0.23%	72
2024 Q2	–	Sell	-116,000	Closed	-$9.25M	–	114
2024 Q1	$9.25M	Hold	116,000	–	–	0.15%	85
2023 Q4	$9.16M	Buy	+116,000	New	+$8.26M	0.38%	47

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capitolis Liquid Global Markets's CVS Position: Q2 2026 in Review

Capitolis Liquid Global Markets reduced its CVS Health (CVS) stake by 37% in Q2 2026, selling an estimated $5.15M and leaving 97,303 shares worth $10.1M. The position accounts for 0.04% of the portfolio, ranked #198.

Capitolis Liquid Global Markets first reported a position in CVS in Q4 2023 and has held it in 7 quarters since. The position peaked at $25.8M in Q1 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Capitolis Liquid Global Markets held 97,303 shares of CVS Health worth $10.1M as of Q2 2026.
Capitolis Liquid Global Markets sold 57,695 CVS Health shares in Q2 2026, an estimated $5.15M.
CVS Health made up 0.04% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #198 holding.
Capitolis Liquid Global Markets first reported a position in CVS Health in Q4 2023 and has held it in 7 quarters since.
Capitolis Liquid Global Markets's CVS Health position peaked at $25.8M in Q1 2025.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.